These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 17634881

  • 1. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.
    Yanaga Y, Awai K, Nakayama Y, Nakaura T, Tamura Y, Funama Y, Aoyama M, Asada N, Yamashita Y.
    Radiat Med; 2007 Jul; 25(6):278-88. PubMed ID: 17634881
    [Abstract] [Full Text] [Related]

  • 2. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations.
    Yagyu Y, Awai K, Inoue M, Watai R, Sano T, Hasegawa H, Nishimura Y.
    AJR Am J Roentgenol; 2005 May; 184(5):1535-40. PubMed ID: 15855112
    [Abstract] [Full Text] [Related]

  • 3. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K, Takada K, Onishi H, Hori S.
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [Abstract] [Full Text] [Related]

  • 4. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K, Inoue M, Yagyu Y, Watanabe M, Sano T, Nin S, Koike R, Nishimura Y, Yamashita Y.
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multidetector CT with double arterial phase and high-iodine-concentration contrast agent in the detection of hepatocellular carcinoma.
    Pozzi Mucelli RM, Como G, Del Frate C, Iuri D, Furlan A, Al-Grhiw E, Bazzocchi M.
    Radiol Med; 2006 Mar; 111(2):181-91. PubMed ID: 16671376
    [Abstract] [Full Text] [Related]

  • 7. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
    Yanaga Y, Awai K, Nakaura T, Namimoto T, Oda S, Funama Y, Yamashita Y.
    AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush.
    Matoba M, Kitadate M, Kondou T, Yokota H, Tonami H.
    AJR Am J Roentgenol; 2009 Sep; 193(3):738-44. PubMed ID: 19696287
    [Abstract] [Full Text] [Related]

  • 13. Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
    Guerrisi A, Marin D, Nelson RC, De Filippis G, Di Martino M, Barnhart H, Masciangelo R, Guerrisi I, Passariello R, Catalano C.
    Br J Radiol; 2011 Aug; 84(1004):698-708. PubMed ID: 21750137
    [Abstract] [Full Text] [Related]

  • 14. Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.
    Yamaguchi I, Kidoya E, Suzuki M, Kimura H.
    Radiol Phys Technol; 2011 Jan; 4(1):43-52. PubMed ID: 20872188
    [Abstract] [Full Text] [Related]

  • 15. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
    Fujigai T, Kumano S, Okada M, Hyodo T, Imaoka I, Yagyu Y, Ashikaga R, Ishii K, Murakami T.
    Eur J Radiol; 2012 Nov; 81(11):2978-83. PubMed ID: 22305012
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.